Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $94.1800 (-3.22%) ($93.3600 - $95.9800) on Fri. Oct. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.65% (three month average) | RSI | 61 | Latest Price | $94.1800(-3.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.7% a day on average for past five trading days. | Weekly Trend | LGND advances 6.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(49%) IWN(48%) IWO(48%) IWC(46%) IBB(43%) | Factors Impacting LGND price | LGND will decline at least -1.325% in a week (0% probabilities). VXX(-16%) UUP(-14%) TBT(-8%) UNG(-6%) VIXM(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.325% (StdDev 2.65%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $93.43(0.8%) | 10 Day Moving Average | $88.57(6.33%) | 20 Day Moving Average | $87.68(7.41%) | To recent high | -12.6% | To recent low | 21.3% | Market Cap | $1.514b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |